Enable Accessibility Enable Accessibility

Director/PDMR Share Dealings

June 30, 2015

June 30, 2015 – Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that Ordinary Shares (“Shares”) and American Depositary Shares (“ADSs”) of the Company, as set out below, have been acquired today for the Non-Executive Directors, being the part of their total fees that are paid in shares for the period of service from April 1 to June 30, 2015.

 
Type of Security (1)
Number of Shares/ADSs
Dominic Blakemore
Shares
114
William Burns
Shares
126
Dr. Steven Gillis
ADSs
40
Dr. David Ginsburg
ADSs
36
David Kappler
Shares
126
Susan Kilsby
ADSs
133
Anne Minto
Shares
128

(1) One ADS is equal to three Shares

The Shares and ADSs were acquired on the London Stock Exchange and NASDAQ respectively at £51.05 per Share and $241.4578 per ADS.

This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.

Tony Guthrie
Deputy Company Secretary 

For further information please contact:

Investor Relations

   
Sarah Elton-Farr seltonfarr@shire.com +44 1256 894157

NOTES TO EDITORS

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.

www.shire.com